The DOI matches its Crossref record; 27 of the 28 references it cites were found in a registry or an index.
. Inflammation and mortality in HIV-infected adults: analysis of the FRAM study cohort.
Open accessAbstract
OBJECTIVE: To determine the association of inflammatory markers, fibrinogen, and C-reactive protein (CRP), with 5-year mortality risk. METHODS: Vital status was ascertained in 922 HIV-infected participants from the Study of Fat Redistribution and Metabolic Change in HIV infection. Multivariable logistic regression estimated odds ratios after adjustment for demographic, cardiovascular, and HIV-related factors. RESULTS: Over a 5-year period, HIV-infected participants with fibrinogen levels in the highest tertile (>406 mg/dL) had 2.6-fold higher adjusted odds of death than those with fibrinogen in the lowest tertile (<319 mg/dL). Those with high CRP (>3 mg/L) had 2.7-fold higher adjusted odds of death than those with CRP <1 mg/L. When stratified by CD4 count category, fibrinogen (as a linear variable) remained independently associated [odds ratio (95% confidence intervals)] per 100 mg/dL increase in fibrinogen: 1.93 (1.57 to 2.37); 1.43 (1.14 to 1.79); 1.43 (1.14 to 1.81); and 1.30 (1.04 to 1.63) for CD4 <200, 200-350, >350 to 500, and >500 cells per microliter, respectively. Higher CRP also remained associated with higher odds of death overall and within each CD4 subgroup. CONCLUSIONS: Fibrinogen and CRP are strong and independent predictors of mortality in HIV-infected adults. Our findings suggest that even in those with relatively preserved CD4 counts >500 cells per microliter, inflammation remains an important risk factor for mortality. Further investigation should determine whether interventions to reduce inflammation might decrease mortality risk in HIV-infected individuals.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The ability of these biomarkers to predict outcome has been observed in most patient populations, including those with preserved immune function (51).”
From HIV and Aging: State of Knowledge and Areas of Critical Need for Research. A Report to the NIH Office of AIDS Research by the HIV and Aging Working Group (2012) · cites this paper as [51]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Palella, F. J., Delaney, K. M., Moorman, A. C., Loveless, M. O., Fuhrer, J., Satten, G. A., Aschman, D. J., & Holmberg, S. D. (1998) · New England Journal of Medicine · doi:10.1056/nejm199803263381301 · Cited by 9,393
Levey, A. S., Coresh, J., Balk, E., Kausz, A. T., Levin, A., Steffes, M. W., Hogg, R. J., Perrone, R. D., Lau, J., & Eknoyan, G. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-2-200307150-00013 · Cited by 4,615
Schafer, J. L. (1999) · Statistical Methods in Medical Research · doi:10.1177/096228029900800102 · Cited by 3,949
Hernán, M. Á., Brumback, B., & Robins, J. M. (2000) · Epidemiology · doi:10.1097/00001648-200009000-00012 · Cited by 1,772
. Inflammatory and coagulation biomarkers and mortality in patients with HIV infection.
Kuller, L. H., Tracy, R., Belloso, W., Wit, S. D., Drummond, F., Lane, H. C., Ledergerber, B., Lundgren, J., Neuhaus, J., Nixon, D., et al. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050203 · Cited by 1,617
Mortality in the Highly Active Antiretroviral Therapy Era
Palella, F. J., Baker, R. K., Moorman, A. C., Chmiel, J. S., Wood, K. C., Brooks, J. T., & Holmberg, S. D. (2006) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/01.qai.0000233310.90484.16 · Cited by 1,362
Plasma Fibrinogen Level and the Risk of Major Cardiovascular Diseases and Nonvascular Mortality
Danesh, J., Lewington, S., Thompson, S. G., Lowe, G. D. O., Collins, R., Kostis, J. B., Wilson, A. C., Folsom, A. R., Wu, K., Benderly, M., et al. (2005) · JAMA · doi:10.1001/jama.294.14.1799 · Cited by 1,162
Liver-Related Deaths in Persons Infected With the Human Immunodeficiency Virus
The Data Collection on Adverse Events of Anti-HIV Drugs Study Group* (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.15.1632 · Cited by 1,115
Effect of Early versus Deferred Antiretroviral Therapy for HIV on Survival
Kitahata, M. M., Gange, S. J., Abraham, A. G., Merriman, B., Saag, M. S., Justice, A. C., Hogg, R. S., Deeks, S. G., Eron, J. J., Brooks, J. T., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0807252 · Cited by 1,105
Relation of C-Reactive Protein and Coronary Heart Disease in the MRFIT Nested Case-Control Study
Kuller, L. H., Tracy, R. P., Shaten, J., & Meilahn, E. N. (1996) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a008963 · Cited by 1,098
Cited by
Sorted by citations
Items 201–279 of 279
Lim, H., Kane, L., Schwartz, J. B., Hesdorffer, C. S., Deeks, S. G., Greig, N. H., Ferrucci, L., & Goetzl, E. J. (2012) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2012.04603.x · Cited by 6
Beck, E. J., Fasawe, O., Ongpin, P., Ghys, P. D., Avilla, C., & Lay, P. R. D. (2013) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1586/erp.13.28 · Cited by 6
Llibre, J. M., Antela, A., Arribas, J. R., Domingo, P., Gatell, J. M., López-Aldeguer, J., Lozano, F., Miralles, C., Moltó, J., Moreno, S., et al. (2010) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/j.eimc.2010.08.004 · Cited by 6
Dubé, M. P. (2014) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiu015 · Cited by 6
Lynch, E. N., & Russo, F. P. (2023) · Life · doi:10.3390/life13101975 · Cited by 5
Chalouni, M., Pol, S., Sogni, P., Fontaine, H., Lacombe, K., Lacombe, J., Esterle, L., Dorival, C., Bourlière, M., Bani‐Sadr, F., et al. (2021) · HIV Medicine · doi:10.1111/hiv.13153 · Cited by 5
Large lessons learned from small vessels: coronary microvascular dysfunction in HIV
Thomas, T. S., Walpert, A. R., & Srinivasa, S. (2023) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000987 · Cited by 5
S, G. M. F., & H, B. S. F. (2015) · Journal of Infectious Diseases and Therapy · doi:10.4172/2332-0877.1000239 · Cited by 5
[Medical treatment of depression during pregnancy and breastfeeding].
Nielsen, R. E., Stage, K. B., Christensen, P. M., Mortensen, S., Andersen, L. L. T., & Damkier, P. (2007) · PubMed · Cited by 5
Russell, E. S., Mohammed, T., Smeaton, L. M., Jorowe, B., MacLeod, I. J., Hoffman, R. M., Currier, J. S., Moyo, S. M., Essex, M., & Lockman, S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0089928 · Cited by 5
FERNANDES, M. K. C., Paula, M. D., Oliveira, R., Santos, J. P. D., Mancini, M. C., & Hottz, E. D. (2026) · Journal of Inflammation Research · doi:10.2147/jir.s556871 · Cited by 4
Etiology of Persistent Microalbuminuria in Nigeria (P_MICRO study): protocol and study design
Wester, C. W., Shepherd, B. E., Wudil, U. J., Musa, B. M., Ingles, D. J., Prigmore, H. L., Dankishiya, F. S., Ahonkhai, A. A., Grema, B. A., Budge, P. J., et al. (2022) · BMC Infectious Diseases · doi:10.1186/s12879-022-07531-y · Cited by 4
HIV Infection and Acute Stroke: A Case Report and a Review of the Literature
Assallum, H., Alkayem, M., & Shabarek, N. (2013) · Case Reports in Medicine · doi:10.1155/2013/892054 · Cited by 4
Piroth, L., Moinot, L., Yéni, P., Avettand-Fènoël, V., Reynes, J., Girard, P., Marchou, B., Georget, A., Rouzioux, C., Autran, B., et al. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv369 · Cited by 4
Murray, D. D., Grund, B., MacPherson, C. R., Ekenberg, C., Zucco, A. G., Reekie, J., Domínguez, L., Leung, P., Fusco, D. N., Gras, J., et al. (2022) · AIDS · doi:10.1097/qad.0000000000003427 · Cited by 4
Kalmin, M. M., Westreich, D. J., Drummond, B., Sun, J., Mehta, S. H., & Kirk, G. D. (2021) · AIDS · doi:10.1097/qad.0000000000002914 · Cited by 4
Premature Onset of Cardiovascular Disease in HIV-Infected Individuals: The Drugs and the Virus
Maisa, A., Westhorpe, C. L. V., Elliott, J., Jaworowski, A., Hearps, A. C., Dart, A. M., Hoy, J., & Crowe, S. M. (2010) · HIV Therapy · doi:10.2217/hiv.10.53 · Cited by 4
Harrison, M., Wolfe, A. S., Fordyce, J., Rock, J. L., García, A. A., & Zuniga, J. A. (2019) · Amino Acids · doi:10.1007/s00726-019-02715-4 · Cited by 3
Assessment of Tp-e interval and Tp-e/QT ratio in patients with human immunodeficiency virus
Çetin, Ş., Çetin, A. Ş., Gürdal, A., Yıldız, S. S., Keskin, K., Sığırcı, S., & Bayraktar, A. (2020) · Revista Portuguesa de Cardiologia · doi:10.1016/j.repc.2019.04.010 · Cited by 3
Gnoni, M. L., Otero, D., Friedstrom, S. R., Blatt, S., & Ramírez, J. A. (2015) · HIV & AIDS Review · doi:10.1016/j.hivar.2015.07.001 · Cited by 3
The impact of HIV on the risk of COVID-19 death among hospitalized patients
Looha, M. A., Taraghikhah, N., Amini, M., Pormehr, P. S., Talaei, N., Khodadoost, M., Gholamzadeh, S., Vafaee, R., & Mohammadi, G. (2023) · Human Antibodies · doi:10.3233/hab-220011 · Cited by 3
Aaron, K. J., Kempf, M.-C., Christenson, R. H., Wilson, C. M., Muntner, P., & Shrestha, S. (2012) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e31826d7421 · Cited by 2
Zanetti, H. R., Soares, V. L., Soares, W. F., Lourenço, C. L. M., Gonçalves, A., Lopes, L. T. P., Roever, L., Silva-Vergara, M. L., Neves, F. F., & Mendes, E. L. (2021) · Minerva Cardiology and Angiology · doi:10.23736/s2724-5683.21.05578-x · Cited by 2
Immune correlates of cardiovascular co-morbidity in HIV infected participants from South India
Kausalya, B., Saravanan, S., Pallikkuth, S., Pahwa, R., Saini, S. R., Iqbal, H. S., Solomon, S. S., Murugavel, K. G., Poongulali, S., Kumarasamy, N., et al. (2022) · BMC Immunology · doi:10.1186/s12865-022-00498-0 · Cited by 2
Stephen, R. I. (2023) · Texila international journal of public health · doi:10.21522/tijph.2013.11.01.art031 · Cited by 3
Gong, K., & Lai, Y. (2023) · Archives of Microbiology · doi:10.1007/s00203-023-03624-7 · Cited by 2
Lawrence, S., Mueller, B. R., Benn, E. K. T., Kim‐Schulze, S., Kwon, P. M., & Robinson‐Papp, J. (2023) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-023-10088-5 · Cited by 2
Adiponectin Levels and Coronary Artery Disease among HIV-Infected Men
Norton, L. (2013) · Journal of AIDS & Clinical Research · doi:10.4172/2155-6113.1000208 · Cited by 2
Serum activities of oxidative burst enzymes in HIV infected subjects
Emokpae, M. A., & Mrakpor, B. A. (2017) · HIV & AIDS Review · doi:10.5114/hivar.2017.67988 · Cited by 2
Human immunodeficiency virus and cerebrovascular diseases – review
Richard, S. A., Tampouri, J., Sackey, M., & Zakariah, A. N. (2017) · HIV & AIDS Review · doi:10.5114/hivar.2017.71874 · Cited by 2
Biochemical clusters predict mortality and reported inability to work 10 years later
Bertele, N., Karabatsiakis, A., Talmon, A., & Buß, C. (2022) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2022.100432 · Cited by 3
Influence of AIDS antiretroviral therapy on the growth pattern
Golucci, A. P. B. S., Marson, F. A. L., Valente, M. F. F., Branco, M. M., Prado, C. C., & Nogueira, R. J. N. (2019) · Jornal de Pediatria (Versão em Português) · doi:10.1016/j.jpedp.2018.05.007 · Cited by 2
Prognosis in acute pancreatitis associated with HIV infection
Anderson, F., Madiba, T. E., & Thomson, S. R. (2022) · HPB · doi:10.1016/j.hpb.2022.06.010 · Cited by 2
Immunosenescence, immunotolerance and rejection: clinical aspects in solid organ transplantation
Rubino, G., & Yörük, E. (2024) · Transplant Immunology · doi:10.1016/j.trim.2024.102068 · Cited by 1
Lembas, A., Załęski, A., Mikuła, T., Kozłowska, J., & Wiercińska‐Drapało, A. (2025) · Viruses · doi:10.3390/v17020243 · Cited by 1
Ciccacci, F., Welu, B., Ndoi, H., Karea, I., Altan, A. M. D., Brambilla, D., Munene, K., Opanga, B., Ronoh, A., Mukwanjagi, S., et al. (2025) · Infectious Diseases Now · doi:10.1016/j.idnow.2025.105100 · Cited by 1
Beddek, K., Boufassa, F., Mouanga, C., Bitu, M., Avettand-Fènoël, V., Lambotte, O., Meyer, L., Goujard, C., Noël, N., Bourgeois, C., et al. (2025) · AIDS · doi:10.1097/qad.0000000000004253 · Cited by 1
Kawasaki-like disease (KLD) in an adult with congenital HIV infection
Saini, V. A., Otero, D., Gnoni, M. L., Cates, D. W., & Ramírez, J. A. (2015) · HIV & AIDS Review · doi:10.1016/j.hivar.2015.10.003 · Cited by 1
Nkhoma, P., Kaile, T., Kwenda, G., Sinkala, M., Mwaba, F., & Mantina, H. M. (2017) · Medical Journal of Zambia · doi:10.55320/mjz.44.2.260 · Cited by 1
Hypertension in Hiv-infected Patients at Boma Hospital in Democratic Republic of the Congo
Nimi, B. M., Mbenza, B. L., Nzuzi, C. N., Vangu, R. V., Nkodila, A. N., Nimi, M. M., Nzita, A. N., & Nkelani, M. L. (2021) · International Journal of HIV/AIDS Prevention Education and Behavioural Science · doi:10.11648/j.ijhpebs.20210701.11 · Cited by 1
Dubé, M. P. (2015) · Springer eBooks · doi:10.1007/978-3-319-11161-2_14 · Cited by 1
Moore-Igwe, B. W., Jacob, R. B., Christian, S. G., & Eze, E. M. (2022) · International Journal of Immunology · doi:10.11648/j.iji.20221001.12 · Cited by 1
Mesić, A., Decroo, T., Florence, É., Ritmeijer, K., van Olmen, J., & Lynen, L. (2023) · International Health · doi:10.1093/inthealth/ihad093 · Cited by 1
Cioe, P. A. (2012) · The Journal of the American Medical Association (JAMA) Network (American Medical Association) · doi:10.13028/585p-sn47 · Cited by 1
Moyle, G. J., Hardy, H., Uy, J. P., Ray, N., Jiménez‐Expósito, M. J., McGrath, D., & DeJesus, E. (2013) · Antiviral Therapy · doi:10.3851/imp2778 · Cited by 1
Gannon, P. J. (2014) · Scholarly Commons (University of Pennsylvania) · Cited by 1
Yıldız, S. S., Çetin, Ş., Keskin, K., Gündüz, A., Çetinkal, G., BÜLBÜN, G., Sığırcı, S., Pilten, S., & Kılıçkesmez, K. (2018) · Journal of Investigative Medicine · doi:10.1136/jim-2018-000859 · Cited by 1
Causas de óbito entre pessoas com aids no município de São Paulo. 1991-2006
Domingues, C. S. B. (2011) · doi:10.11606/d.6.2011.tde-05122011-112240 · Cited by 1
Gunthel, C. J., & Lechowicz, M. J. (2016) · Cancer · doi:10.1002/cncr.30110 · Cited by 1
Wohl, D. A., Kendall, M. A., Feinberg, J., Alston‐Smith, B., Owens, S., Chafey, S., Marco, M., Maxwell, S., Benson, C. A., Keiser, P. H., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0078676
Cardiac Biomarkers in Persons With HIV Infection: A Review of the Literature
Chandler, C., & Dorsen, C. G. (2013) · Journal of the Association of Nurses in AIDS Care · doi:10.1016/j.jana.2012.11.007
Drugs of Abuse and NeuroAIDS: Opiates
Rogers, T. J. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1071-7_22
Petrilli, A. A. (2015) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.6.2015.tde-21082015-135240
Lladó, L. I. (2014) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Silva, L. F. D., & Neto, P. G. F. (2012)
Similarities in Asymptomatic HIV Infection and Cancer: A Common 'Driver' Hypothesis
Samuel, M. (2017) · Cancer and Oncology Research · doi:10.13189/cor.2017.050201
Gandhi, S. (2014) · Digital Commons @ UNT Health Science Center
HIV, Immune activation and Endothelial Damage in Malawian Adults
Kelly, C. (2017) · University of Liverpool · doi:10.17638/03006512
Heart Failure and Human Immunodeficiency Virus
Bloomfield, G. S., Feinstein, M. J., & Longenecker, C. T. (2020) · Elsevier eBooks · doi:10.1016/b978-0-323-60987-6.00030-2
Association of HSCRP with an Increased Risk of Cardiovascular Events in Rattus norvegicus
Iddah, M. A., & Busolo, H. (2020) · EAS Journal of Pharmacy and Pharmacology · doi:10.36349/easjpp.2020.v02i06.004
HEFFICON: HIV Effectiveness Italian Conference.
Antinori, A., Andreoni, M., Perno, C. F., & Lazzarin, A. (2015) · PubMed
(2011) · Current Opinion in Neurology · doi:10.1097/wco.0b013e328347b40e
Assessment of Tp-e interval and Tp-e/QT ratio in patients with human immunodeficiency virus
Çetin, Ş., Çetin, A. Ş., Gürdal, A., Yıldız, S. S., Keskin, K., Sığırcı, S., & Bayraktar, A. (2020) · Revista Portuguesa de Cardiologia (English Edition) · doi:10.1016/j.repce.2019.04.002
Guo, F., Chen, J., & Zhang, H. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1503614
Kelly, A., Lekgwara, P., & Mda, S. (2025) · Interdisciplinary Neurosurgery · doi:10.1016/j.inat.2025.102003
PIRO-Based Approach for Sepsis in Immunocompromised Patients: What’s Different?
Salluh, J. I., Bozza, F. A., Japiassú, A. M., & Soares, M. (2011) · Springer eBooks · doi:10.1007/978-3-642-03519-7_5
Wester, C. W., Shepherd, B. E., Wudil, U. J., Musa, B. M., Ingles, D. J., Prigmore, H. L., Dankishiya, F. S., Ahonkhai, A. A., Grema, B. A., Budge, P. J., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20227085
Merlini, E., Cozzi‐Lepri, A., Castagna, A., Costantini, A., Caputo, S. L., Carrara, S., Roldan, E. Q., Ursitti, M. A., Antinori, A., d'Arminio-Monforte, A., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14773922
Wester, C. W., Shepherd, B. E., Wudil, U. J., Musa, B. M., Ingles, D. J., Prigmore, H. L., Dankishiya, F. S., Ahonkhai, A. A., Grema, B. A., Budge, P. J., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20227091
Kausalya, B., Saravanan, S., Pallikkuth, S., Pahwa, R. N., Saini, S. R., Iqbal, H. S., Solomon, S., Murugavel, K. G., Poongulali, S., Kumarasamy, N., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19785635
Pronostic à long terme des personnes diagnostiquées en primo-infection VIH-1
Novelli, S. (2020) · theses.fr (ABES) · doi:10.70675/633fb1a8zca74z4cc3zb003z70ea3468cd35
Impact pronostique des comorbidités chez les personnes vivant avec le VIH âgées de 60 ans et plus.
Hentzien, M. (2018) · theses.fr (ABES) · doi:10.70675/303edaceze3f0z427fza5cdz191b7ed8570a
Perez, M. D., Zhu, F., Carlin, E., Greer, B. D., Schroeder, A. R., Lowman, K. E., Opsteen, S., Fram, T., Tidwell, C., Duverger, A. E., et al. (2026) · The Journal of Immunology · doi:10.1093/jimmun/vkag208
Ranzani, F. A., Montrucchio, C., Ferrocino, I., Penoncelli, D., Cavecchia, I., Tettoni, M. C., Ferrara, M., Pezzana, A., Palermiti, A., Lazzaro, A., et al. (2026) · HIV Medicine · doi:10.1111/hiv.70291
Parâmetros imunovirológicos em pacientes infectados pelo HIV, tratados ou não com antirretrovirais
Tasca, K. I. (2012) · Americanae (AECID Library)
Metadata
- Authors
- Tien, P. C., Choi, A. I., Zolopa, A. R., Benson, C., Tracy, R., Scherzer, R., Bacchetti, P., Shlipak, M., & Grunfeld, C.
- Affiliations
- San Francisco VA Medical Center (US)
- Stanford Medicine (US)
- University of California San Diego (US)
- University of California, San Francisco (US)
- Corresponding author
- Tien, Phyllis C
- Choi, Andy I
- Scherzer, Rebecca
- Shlipak, Michael
- ORCID
- Venue
- JAIDS Journal of Acquired Immune Deficiency Syndromes
- Published
- 2010-11-01
- Volume
- 55
- Issue
- 3
- Pages
- 316-322
- ISSN
- 1525-4135 (ISSN-L)
- PMC
- PMC2955817
- OpenAlex
- W2046166857
- Cited by
- 279
- References
- 28
- Citations by year
- 2026: 3 · 2025: 6 · 2024: 3 · 2023: 10 · 2022: 16 · 2021: 17 · 2020: 15 · 2019: 13 · 2018: 18 · 2017: 21 · 2016: 26 · 2015: 23 · 2014: 24 · 2013: 31 · 2012: 25
- FWCI
- 25.25
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- JAIDS Journal of Acquired Immune Deficiency Syndromes (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (2m01rr000083-41)
- National Heart, Lung, and Blood Institute (HL-53359, R01HL053359, HL-74814, R01HL074814)
- National Institute of Allergy and Infectious Diseases (K23AI066943)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK080645, R01DK057508, K23DK080645)
- National Center for Research Resources (RR00054, UL1RR024131, RR-00051, RR 0636, M01RR000054, M01RR000051, RR 000 52, M01RR000052, M01-RR000083, RR00865, M01RR000865, RR 00083, M01RR000036)
- Topics
- Health Sciences › Medicine › Infectious Diseases › HIV-related health complications and treatments
- Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
- Health Sciences › Medicine › Infectious Diseases › HIV/AIDS Research and Interventions
- Keywords
- HIV infection, inflammation, mortality, fibrinogen, C-reactive protein, inflammatory markers, CD4 count, mortality risk factors
- MeSH terms
- Adult, C-Reactive Protein, Female, Fibrinogen, Humans, Inflammation, Male, Middle Aged, Prognosis, HIV Infections, Survival Analysis, CD4 Lymphocyte Count
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
